Aigen Investment Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,898
Closed -$293K 984
2024
Q3
$293K Buy
+7,898
New +$295K 0.06% 478
2024
Q1
Sell
-11,166
Closed -$348K 990
2023
Q4
$348K Sell
11,166
-2,793
-20% -$100K 0.06% 444
2023
Q3
$561K Buy
13,959
+3,040
+28% +$142K 0.11% 314
2023
Q2
$574K Buy
+10,919
New +$665K 0.08% 316
2023
Q1
Sell
-15,878
Closed -$771K 816
2022
Q4
$771K Buy
+15,878
New +$996K 0.11% 197
2022
Q1
Sell
-3,608
Closed -$330K 1037
2021
Q4
$330K Buy
3,608
+1,771
+96% +$190K 0.02% 763
2021
Q3
$236K Buy
+1,837
New +$257K 0.05% 387
2021
Q2
Sell
-3,090
Closed -$326K 720
2021
Q1
$326K Buy
+3,090
New +$309K 0.04% 393
2020
Q1
Sell
-1,748
Closed -$61K 1545
2019
Q4
$61K Buy
+1,748
New +$57.7K 0.01% 781

Other funds holding STAA

Aigen Investment Management's STAA Position: Q4 2024 in Review

Aigen Investment Management sold out of STAAR Surgical (STAA) in Q4 2024, closing a stake of 7,898 shares — an estimated $293K sold.

Aigen Investment Management first reported a position in STAA in Q4 2019 and held it in 9 quarters. The position peaked at $771K in Q4 2022. 212 funds tracked by Wall St. Rank hold STAA as of Q4 2024.

  • Aigen Investment Management reported no remaining STAAR Surgical position as of Q4 2024 after selling out during the quarter.
  • Aigen Investment Management sold 7,898 STAAR Surgical shares in Q4 2024, an estimated $293K.
  • Aigen Investment Management first reported a position in STAAR Surgical in Q4 2019 and held it in 9 quarters.
  • Aigen Investment Management's STAAR Surgical position peaked at $771K in Q4 2022.
  • 212 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2024.

Based on Aigen Investment Management's 13F filing for Q4 2024, filed 6 Feb 2025.